Brian and Tom are joined by Dr. Chris Sweeney of The University of Adelaide, along with Rob Jones of the University of Glasgow, to discuss the merits of various ARPIs in prostate cancer.
Brian and Tom are joined by Dr. Chris Sweeney of The University of Adelaide, along with Rob Jones of the University of Glasgow, to discuss the merits of various ARPIs in prostate cancer.